Editor-in-Chief:

Allen B. Reitz
Prof. of Chemical Biology
Institute of Hepatitis and Virus Research
CEO, Fox C hase Chemical Diversity Center, Incorporation
Doylestown, PA 18902
USA

Co-Editor-in-Chief:

González-Díaz H, Ph.D
Department of Microbiology & Parasitology
Faculty of Pharmacy
University of Santiago de Compostela
Santiago de Compostela, 15782, Spain

Associate Editor:

Rhoda W. Joseph
Fox Chase Chemical Diversity Center, Inc
Doylestown, PA 18902
USA



Section Editors:

Chemical Biology
G. Bertho (Université Paris Descartes, Paris, France)

Cardiovascular
B.E. Blass (Temple University School of Pharmacy, Philadelphia, PA, USA)

Central Nervous System
M. L Bolognesi (University of Bologna, Bologna, Italy)
Liming Shao (Sunovion Pharmaceuticals, Inc., Marlborough, MA, USA)

Oncology
J. P. Bowen (Mercer University, Atlanta, Georgia)

Bioorganic Chemistry
David Fairlie (University of Queensland Chemical Biology. St. Lucia, Australia)

Inflammation and Immunology
W. Kinney (IteraMed Consulting, Doylestown, PA, USA)

Infectious Disease
E.C.T. Supuran (Università degli Studi di Firenze, Florence, Italy)

Editorial Advisory Board:

M.A. Abou-Gharbia (Temple University, Philadelphia, PA, USA)
C. Aldrich (University of Minneapolis, Minneapolis, MN, USA)
A.D. Andricopulo (University of São Paulo, São Paulo, Brazil)
J. Aubé (University of Kansas, Lawrence, KS, USA)
B.N. Balasubramanian (Bristol-Myers Squibb, Princeton, NJ, USA)
E.W. Baxter (Johnson & Johnson PRD, Spring House, PA, USA)
P. Bernhardt (University of Queensland, Brisbane, Australia)
G.W. Caldwell (Johnson & Johnson PRD, Spring House, PA, USA)
F.I. Carroll (Research Triangle Institute, Research Triangle Park, NC, USA)
N.A. Colabufo (University of Bari, Bari, Italy)
J.M. Cook (University of Wisconsin, Milwaukee, WI, USA)
T. Dickerson (Scripps Research Institute, La Jolla, CA, USA)
J. Dinges (Abbott Laboratories, Abbott Park, IL, USA)
G.I. Georg (University of Kansas, Lawrence, KS, USA)
R. Giuliano (Villanova University, Villanova, PA, USA)
R.A. Glennon (Virginia Commonwealth University, Richmond, VA, USA)
P.R. Hanson (University of Kansas, Lawrence, KS, USA)
G. Hartman (Novira Therapeutics, Inc., Philadelphia, PA, USA)
R.L. Hudkins (Cephalon, Inc., West Chester, PA, USA)
D. Huryn (University of Pennsylvania, Philadelphia, PA, USA)
K.A. Jacobson (National Institutes of Health, Bethesda, MD, USA)
E. Juaristi (CINVESTAV-IPN, Mexico City, México)
S.A. Khedkar (Harvard Medical School (BIDMC), Boston, MA, USA)
M. Koufaki (Institute of Organic and Pharmaceutical Chemistry, Athens, Greece)
A.P. Kozikowski (University of Illinois at Chicago, Chicago, IL, USA)
J. Lee (Green Cross Corp., Yongin, Korea)
J.E. Macor (Bristol-Myers Squibb, Wallingford, CT, USA)
B.E. Maryanoff (The Scripps Research Institute, La Jolla, CA, USA)
R. Mata (Universidad Nacional Autónoma de México, Mexico City, México)
S. McAlpine (San Diego State University, San Diego, CA, USA)
M. McDonnell (Fox Chase Chemical Diversity Center, Doylestown, PA, USA)
M. Micha-Screttas (National Hellenic Research Foundation, Athens, Greece)
D.D. Miller (University of Tennessee, Memphis, TN, USA)
G. Molander (University of Pennsylvania, Philadelphia, PA, USA)
K.V. Morris (The Scripps Research Institute, La Jolla, CA, USA)
R.P. Nargund (Merck Research Laboratories, Rahway, NJ, USA)
I. Ojima (State University of New York, Stony Brook, NY, USA)
M.R. Player (Johnson & Johnson PRD, Spring House, PA, USA)
Z. Rankovic (Organon Research Consultancy, Scotland, UK)
J. Regan (Manhattan College, Riverdale, NY, USA)
D.R. Richardson ( University of Sydney, NSW, Sydney, Australia)
J.A. Secrist III (Southern Research Institute, Birmingham, AL, USA)
S.M. Sieburth (Temple University, Philadelphia, PA, USA)
G.R. Smith (Fox Chase Chemical Diversity Center, Inc., Doylestown, PA, USA)
B.B. Snider (Brandeis University, Waltham, MA, USA)
J.P. Vacca (Merck Research Laboratories, West Point, PA, USA)
O. Wiest (University of Notre Dame, Notre Dame, IN, USA)
N.Z. Zevirov (Moscow State University, Moscow, Russia)